Slide 1 Rational use of drugs: an overview Kathleen Holloway Technical Briefing Seminar November 2008 Department of Essential Medicines and Pharmaceutical Policy TBS 2008…

Slide 1 1 Regulatory Legislation and Guidelines for Recombinant Drugs, Pharmaceuticals and Biologicals K.K. Tripathi* Department of Biotechnology (Ministry of Science and…

Slide 1  IMS Health 2011 Strengths and Limitations of Market Intelligence Data for Pharmaceutical Policy Analysis in LMIC ICIUM 2011 - Third International Conference for…

Pharmaceutical Policy â Focus on Pricing, Reimbursement and Industrial Policy Andreas Seiter October 2006 Tehran Pharmaceutical Policy Goals Access to medicines Cost control…

Gender and Access to Medicines in 15 Low- and Middle-Income Countries: Does Physician Prescribing for Men and Women Differ?  Stephens, Peter (1); Ross-Degnan, Dennis (2);…

Regulatory Legislation and Guidelines for Recombinant Drugs, Pharmaceuticals and Biologicals K.K. Tripathi* Department of Biotechnology (Ministry of Science and Technology),…

Pharmaceutical Policy in Canada: Reflections on a Shifting Landscape Steve Morgan, PhD Centre for Health Services and Policy Research University of British Columbia T H E…

Moving from Professional-Directed to Patient-Centered Behavior Change Policy, Advocacy, and Regulation, One Health Course Images from www.somona.edu Policy, advocacy, and…

Annual Report 2012

PII: S0168-8510(98)00002-5Dilemmas in drug development for tropical diseases Experiences with praziquantel Michael R. Reich a,*, Ramesh Govindaraj b a Department of Population